HC Wainwright & Co. analyst Robert Burns downgrades TCR2 Therapeutics (NASDAQ:TCRR) from Buy to Neutral.
Microsoft’s Blizzard Teases Diablo IV Season 3 Launch Date
Microsoft Corp.'s (NASDAQ: MSFT) Blizzard Entertainment is set to launch Diablo IV Season 3 on Jan. 23, as indicated by an update on the game's login screen.